Literature DB >> 7686716

Detection of antibody to hepatitis C virus by second-generation enzyme immunoassay.

R K Chaudhary1, C Maclean.   

Abstract

Of 106 samples positive for antibody to hepatitis C virus (anti-HCV) by first-generation enzyme immunoassay (EIA-1), 63 (59%), 67 (63%) and 43 (41%) were reactive by second-generation EIAs (EIA-2). Among positive EIA-1 samples, 33% were reactive by second-generation recombinant immunoblot assay (RIBA-2). A higher percentage of positive EIA-2 samples, however, were reactive by RIBA-2. In the high-risk group there was a correlation between the EIA-2 and RIBA-2 results. In the low-risk group, however, the correlation was poor except in blood donors, in whom 57% of samples were reactive by EIA-2 and RIBA-2. Results showed that the sensitivity and specificity of EIA-2s has improved although further improvement is desirable.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686716     DOI: 10.1093/ajcp/99.6.702

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Performance of third-generation confirmatory tests for detection of antibody to hepatitis C virus.

Authors:  R K Chaudhary; H Jacobsen
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

2.  Evaluation of indeterminate sera for hepatitis C virus by assays using synthetic peptides.

Authors:  D Rivanera; G Lorino; D Lilli; G Dicuonzo; C Mancini
Journal:  Eur J Epidemiol       Date:  1994-04       Impact factor: 8.082

3.  Quantitation of hepatitis C viral RNA in liver and serum samples using competitive polymerase chain reaction.

Authors:  M Sugano; Y Hayashi; S Yoon; M Kinoshita; T Ninomiya; K Ohta; H Itoh; M Kasuga
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

4.  Low Specificity of the Third Generation Elisa for HCV Detection in Voluntary Blood Donors in India.

Authors:  V Thakur; R C Guptan; V Arankale; S K Sarin
Journal:  EJIFCC       Date:  2003-04-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.